KRON
Income statement / Annual
Last year (2023), Kronos Bio, Inc.'s total revenue was $6.29 M,
and the percentage change from the previous year is not available.
In 2023, Kronos Bio, Inc.'s net income was -$112.67 M.
See Kronos Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$6.29 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$4.92 M |
$4.46 M |
$4.08 M |
$4.87 M |
$605,000.00 |
$160,000.00 |
| Gross Profit |
$1.37 M |
-$4.46 M |
-$4.08 M |
-$4.87 M |
-$605,000.00 |
-$160,000.00 |
| Gross Profit Ratio |
0.22 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$86.38 M
|
$93.72 M
|
$112.90 M
|
$43.25 M
|
$13.45 M
|
$5.03 M
|
| General & Administrative
Expenses |
$41.74 M
|
$43.40 M
|
$38.50 M
|
$14.79 M
|
$3.37 M
|
$1.61 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$41.74 M
|
$43.40 M
|
$38.50 M
|
$14.79 M
|
$3.37 M
|
$1.61 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
-$27.41 M |
$0.00 |
$0.00 |
| Operating Expenses |
$128.12 M |
$137.12 M |
$151.40 M |
$58.04 M |
$16.82 M |
$6.65 M |
| Cost And Expenses |
$128.12 M |
$137.12 M |
$151.40 M |
$58.04 M |
$16.82 M |
$6.65 M |
| Interest Income |
$9.16 M |
$3.91 M |
$320,000.00 |
$898,000.00 |
$699,000.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$3.89 M |
$0.00 |
$76,000.00 |
| Depreciation &
Amortization |
$2.14 M
|
$4.46 M
|
$4.08 M
|
$4.87 M
|
$605,000.00
|
$160,000.00
|
| EBITDA |
-$121.83 M
|
-$128.74 M
|
-$147.00 M
|
-$79.69 M
|
-$15.51 M
|
-$6.49 M
|
| EBITDA Ratio |
-19.38 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-19.38
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$9.16 M
|
$3.91 M
|
$320,000.00
|
-$30.40 M
|
$699,000.00
|
-$76,000.00
|
| Income Before Tax |
-$112.67 M |
-$133.20 M |
-$151.08 M |
-$88.44 M |
-$16.12 M |
-$6.72 M |
| Income Before Tax Ratio
|
-17.92
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$3.91 M |
-$1.98 M |
-$24.36 M |
-$699,000.00 |
-$70,141.00 |
| Net Income |
-$112.67 M |
-$129.29 M |
-$149.10 M |
-$64.09 M |
-$15.42 M |
-$6.72 M |
| Net Income Ratio |
-17.92 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.95 |
-2.3 |
-2.72 |
-1.19 |
-0.29 |
-0.24 |
| EPS Diluted |
-1.95 |
-2.3 |
-2.72 |
-1.19 |
-0.29 |
-0.24 |
| Weighted Average Shares
Out |
$57.74 M
|
$56.20 M
|
$54.75 M
|
$54.07 M
|
$53.04 M
|
$28.45 M
|
| Weighted Average Shares
Out Diluted |
$57.74 M
|
$56.20 M
|
$54.75 M
|
$54.07 M
|
$53.04 M
|
$28.45 M
|
| Link |
|
|
|
|
|
|
